Uterotrophic Effects of Testosterone and 5α-Dihydrotestosterone in Intact and Ovariectomized Immature Female Rats
- 1 August 1976
- journal article
- research article
- Published by Oxford University Press (OUP) in Biology of Reproduction
- Vol. 15 (1), 107-114
- https://doi.org/10.1095/biolreprod15.1.107
Abstract
The relative effectiveness of exogenous testosterone and 5α-dihydrotestosterone (DHT) in causing uterine growth in intact vs ovariectomized immature rats has been investigated to determine the extent to which the uterotrophic responses to these androgens depends upon their aromatization in the ovaries. Ovariectomy depressed the ability of testosterone to a much greater extent than that of DHT to induce uterine growth, especially hypertrophy of the uterine luminal epithelial cells. This ability was not further decreased by adrenalectomy. Exogenous estradiol-17β administration was as effective in stimulating uterine growth and increased luminal epithelial cell height in ovariectomized rats treated with DHT as in those treated with testosterone, indicating that the decreased effectiveness of DHT to induce these changes was not the result of greater anti-estrogenic activity of DHT than of testosterone. Ovarian contents of immunoreactive estradiol-17β increased markedly, and approximately in parallel with increased ovarian contents of immunoreactive testosterone + DHT 6 and 12 h after s.c. injection of testosterone; by 24 h, ovarian contents of both steroids declined approximately to pre-injection levels. In contrast, s.c. injection of DHT was followed by significantly decreased ovarian contents of estradiol-17β at all 3 time intervals. It is concluded that increased ovarian formation of estradiol-17β occurs when ovarian contents of testosterone are elevated by administration of high dosages of exogenous testosterone to immature rats, and that this estrogen contributes significantly to the uterine growth and histologic changes which follow testosterone administration. The lack of such changes as a result of DHT administration attests to the inability of this androgen to undergo aromatization in vivo; the decreased ovarian content of estradiol-17β following DHT administration suggests that this steroid, in addition to being ineffectual as an estrogen precursor, may actually play a role in inhibition of ovarian estrogen biosynthesis.This publication has 1 reference indexed in Scilit: